CTE Study Shows 25% of Deceased NFL Players Affected – A Global Call for Reform

The Number That Changes Everything

Twenty-five percent. That is the share of deceased former NFL players who had CTE, according to a study published Tuesday in The British Medical Journal. The researchers tested brain tissue from 235 of the 878 players who died between 2016 and 2021. Two hundred fifteen carried the disease.

But the number is almost certainly an underestimate. The sample only includes players whose families chose to donate brains to Boston University’s UNITE Brain Bank—a self-selected group likely to have noticed neurological symptoms. The authors themselves warned that the true prevalence could be higher. When a headline figure is already staggering, the acknowledgment that it may be conservative shifts the entire weight of the evidence.

Beyond the Gridiron: How This Reshapes Global Football

American football is no longer a purely domestic product. Flags and tackle leagues operate in more than 60 countries, with professional competitions in Europe, Latin America, and Asia. International sponsors—from telecom giants to sporting goods brands—have long tied their marketing to the NFL’s global expansion. Each new study like this one adds a liability multiplier to that picture.

Rugby, ice hockey, and boxing have faced their own traumatic-brain-injury reckonings. But the NFL’s scale means its data gets amplified fastest. When a major American sports league produces peer-reviewed evidence that a quarter of its deceased players suffered a degenerative brain disease, federations worldwide will revisit safety protocols. Youth programs in Canada, Germany, and Australia will feel immediate pressure from parents and insurers. The game’s commercial footprint may shrink in markets where the risk becomes too obvious to ignore.

The Liability Ticking Bomb

Legal exposure is where the 25% figure will be felt most acutely. The NFL has already set aside billions for player‑illness claims, but those funds were based on older, smaller studies. A BMJ publication with a sample this large and a methodology this rigorous gives plaintiffs’ attorneys a powerful new benchmark. Class‑action suits, workers‑compishments claims, and state‑level litigation are all likely to intensify.

Who wins in that landscape? Former players and their families, who have waited decades for recognition. Who loses? NFL shareholders, insurance carriers, and any entity that bets on the league’s liability remaining capped. The timeline is predictable: each new peer‑reviewed study will reset the baseline for settlement negotiations. The next wave of data—perhaps breaking down risk by position, era, or number of seasons—will only add fuel.

Youth Football at a Crossroads

Participation in youth tackle football has been sliding for years, driven by safety concerns, rising costs, and competition from other sports. This study will not reverse the trend on its own, but it will deepen the parental calculus. A quarter of deceased former players had CTE; the real risk for a 10‑year‑old is still unknown. That uncertainty is exactly what drives enrollment down.

Programs that invest in newer helmet standards, limit contact in practice, and fund independent health monitoring may weather the drop. Those that cling to “we’ve always done it this way” will lose families to flag football, soccer, or esports. The lesson for coaches and administrators is simple: transparency about risk—and visible investment in mitigation—is no longer optional.

The Scientific Imperative

The UNITE Brain Bank now holds tissue from more than 330 players who died between 2008 and 2021. That growing archive is the lifeblood of research into CTE’s progression, genetic susceptibilities, and the exact impact thresholds that trigger pathology. Future studies will likely isolate patterns by position—linemen take far more repetitive subconcussive hits than receivers—and by era, as rule changes altered the nature of collisions.

Researchers at Mass General Brigham, led by Dr. Daniel Daneshvar, have turned a tragic collection of donations into a roadmap for prevention. The win here is knowledge itself; the loss is the players who died before their symptoms could be matched to the disease. Longitudinal studies of living former players, combined with wearable sensor data, will soon give scientists a real‑time view of exposure that post‑mortem samples alone cannot provide.

The League’s Dilemma

The NFL’s statement to NPR reiterated its commitment to “make the game of football safer” and highlighted an expanding set of mental‑health resources. That language is standard after any major study. What it does not address is the gap between resource availability and actual access—especially for retired players who lack employer‑sponsored insurance or live far from specialist clinics.

If the league wants to preserve its credibility domestically and abroad, it must move beyond statements. Concrete steps would include: mandatory independent neurological screening for all retired players, fully funded treatment pathways, and transparent sharing of all player‑health data with independent researchers. The teams and the league office stand to gain nothing from opacity; they stand to lose enormous goodwill and legal leverage.

A Call for Ecosystem‑Wide Action

The NFL Players Association, through its email to members, framed the findings as “a call to action across the entire football ecosystem.” That phrase is meant to include youth leagues, college programs, equipment manufacturers, broadcasters, and sponsors. No single node can fix a problem this entrenched.

Who wins when the ecosystem shares responsibility? Players at every level, their families, and the sport’s long‑term viability. Who loses? Anyone who profits from minimized risk—whether through cheap equipment, aggressive scheduling, or silence about injuries. The next practical steps are likely to be independent oversight boards, standardized safety metrics, and global lobbying for research funding that matches the scale of the problem.

The Ripple Effect

A single percentage point—25%—does not solve a puzzle decades in the making. It adds a decisive piece. For the NFL, it is a benchmark that will be cited in courtrooms, boardrooms, and parent‑teacher conferences for years. For the rest of the world, it is a mirror held up to any sport that normalizes repeated head trauma.

The story’s end point is not set. New data will arrive. Lawsuits will evolve. Participation rates will shift. What is clear is that the era of treating CTE as an obscure post‑mortem finding is over. The numbers are public, the science is peer‑reviewed, and the responsibility is now distributed across every organization that fields players. The question is no longer whether the football ecosystem will act—it is whether it will act before another generation pays the cost.